Author

J. U. Jung

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4 Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 3 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

Y. K. Choi· 3 shared C.-J. Lai· 2 shared D. Kim· 2 shared H. Kim· 2 shared M. A. B. Casel· 2 shared S. Kim· 2 shared S.-G. Jang· 2 shared Y.-i. Kim· 2 shared

Activity by Year

2018-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

Y. K. Choi

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Self-assembling Gn head ferritin nanoparticle vaccine provides full protection from lethal challenge of Dabie Bandavirus in aged ferrets

J. U. Jung, D. Kim, E. Kim, S. Kim, Y. Chung, S.-D. Cho, Y. Choi, C.-J. Lai, X. Dai, S. Kang, M.-J. Kwak, I. Cha, Z. Liu, Y. Choi, S.-H. Park, , S. Kim

This paper develops a self-assembling ferritin nanoparticle vaccine targeting DBV Gn head region that fully protects aged ferrets from lethal DBV challenge.

bioRxiv · Jul 19, 2023Microbiology

Immunometabolic rewiring in long COVID patients with chronic headache

S.-S. Foo, W. Chen, K. L. Jung, T. Azamor, U. Y. Choi, P. Zhang, S. A. Comhair, S. C. Erzurum, L. Jehi, J. U. Jung

This study analyzes multi-omics data from long COVID patients with chronic headache to identify immunometabolic changes associated with the condition.

bioRxiv · Mar 6, 2023 · PreprintMicrobiology

SARS-CoV-2 variants show temperature-dependent enhanced polymerase activity in the upper respiratory tract and high transmissibility

S.-M. Kim, E.-H. Kim, M. A. B. Casel, Y.-i. Kim, R. Sun, M.-J. Kwack, J.-S. Yoo, M.-A. Yoo, K.-M. Yoo, S.-G. Jang, R. Rollon, J. H. Choi, J. Gil, K. Eun, H. Kim, , Y. K. Choi

This study shows SARS-CoV-2 variants with P323L or P323L/G671S mutations in NSP12 have enhanced polymerase activity at 33°C and higher transmissibility in ferrets.

bioRxiv · Sep 27, 2022 · PreprintMicrobiology

Development of spike receptor-binding domain nanoparticle as a vaccine candidate against SARS-CoV-2 infection in ferrets

Y.-I. Kim, D. Kim, K.-M. Yu, H. D. Seo, S.-A. Lee, M. A. B. Casel, S.-G. Jang, S. Kim, W. Jung, C.-J. Lai, Y. K. Choi, J. U. Jung

This study develops a RBD-based nanoparticle vaccine against SARS-CoV-2 that protects ferrets from infection and reduces viral load.

bioRxiv · Jan 28, 2021Immunology

Activation of RIG-I-mediated antiviral signaling triggers autophagy through the MAVS-TRAF6-Beclin-1 signaling axis

K.-S. Inn, N.-R. Lee, J. Ban, N.-J. Lee, C.-M. Yi, J. Choi, H. Kim, J.-K. Lee, J. Seong, N.-H. Cho, J. U. Jung

This study shows that RIG-I activates autophagy via the MAVS-TRAF6-Beclin-1 axis to control viral replication and limit excessive interferon response.

bioRxiv · Jun 6, 2018Immunology

Repurposing cytarabine for treating primary effusion lymphoma by targeting KSHV latent and lytic replications

M. Gruffaz, S. Zhou, K. Vasan, T. Rushing, Q. L. Michael, C. Lu, J. U. Jung, S.-J. Gao

This study identifies cytarabine as a potent inhibitor of KSHV-induced primary effusion lymphoma by targeting both viral and host DNA/RNA synthesis and inducing tumor regression in a xenograft model.

bioRxiv · Apr 11, 2018Microbiology